Evidence map›Paper›PMID 41926539›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

The biased adenosine-rich content of the HIV-1 genome serves as a molecular signature that facilitates efficient packaging.

Hung R Vuong, Qianzi Zhou, Sydney L Lesko, Kasyap Tenneti, Keanu Davis, Shanyqua Scott, Moming Guo, Daphne Boodwa-Ko, Jenna E Eschbach, Kamya Gopal and 10 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Hung R VuongDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110.
Qianzi ZhouDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110.
Sydney L LeskoMcArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin-Madison, Madison, WI 53705.ORCID 0000-0002-2344-8575
Kasyap TennetiDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110.
Keanu DavisDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110.ORCID 0000-0002-4256-9911
Shanyqua ScottMcArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin-Madison, Madison, WI 53705.ORCID 0009-0003-5438-6682
Moming GuoDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110.
Daphne Boodwa-KoDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110.ORCID 0000-0002-5789-2164
Jenna E EschbachDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110.
Kamya GopalCell and Molecular Biology Program, University of Michigan Medical School, Ann Arbor, MI 48109.
Jessica M PorterDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110.ORCID 0009-0000-5298-1881
Qibo WangDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110.ORCID 0009-0003-3337-0833
Ming XiaDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110.
Anthony BoatengDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110.ORCID 0009-0000-4527-6519
Yiqing WangDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110.
Shawn MohammedDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110.
Nakyung LeeDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110.
Alice TelesnitskyCell and Molecular Biology Program, University of Michigan Medical School, Ann Arbor, MI 48109.ORCID 0000-0001-9878-5931
Nathan M ShererMcArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin-Madison, Madison, WI 53705.ORCID 0000-0001-9974-236X
Sebla B KutluayDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110.ORCID 0000-0001-5549-7032

Funding

Center for Structural Biology of HIV RNAU54AI170660 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ALICE TELESNITSKY · 2022 to 2026
$32.1M
Infectious Diseases/Basic Microbial Pathogenic MechanismsT32AI007172 · NIAID · WASHINGTON UNIVERSITY · PI Daniel E. Goldberg, JENNIFER A PHILIPS · 1985 to 2026
$13.0M
The Cell Biology of HIV-1 Genome TraffickingR01AI110221 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI Nathan M Sherer · 2014 to 2026
$4.4M
Selective packaging and protection of HIV-1 genomic RNAsR01AI179691 · NIAID · WASHINGTON UNIVERSITY · PI Sebla B. Kutluay · 2024 to 2026
$2.2M
The Cell Biology of HIV-1 Genome TraffickingR56AI110221 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI SHERER, NATHAN M · 2024 to 2024
$457k
HHS | NIH | NIAID | Division of Intramural Research (DIR) AI110221HHS | NIH | NIAID | Division of Intramural Research (DIR) AI170660HHS | NIH | NIAID | Division of Intramural Research (DIR) AI179691HHS | NIH | NIAID | Division of Intramural Research (DIR) T32AI007172NIAID NIH HHS R01 AI110221NIAID NIH HHS R01 AI179691NIAID NIH HHS R56 AI110221NIAID NIH HHS T32 AI007172NIAID NIH HHS U54 AI170660NSF (NSF) DGE-1745038NSF (NSF) DGE-2139839
6 · The paper itself

Abstract

The HIV-1 genome [genomic RNA (gRNA)] has an unusually biased nucleotide content and is rich in adenosines. Selective packaging of the gRNA is thought to be driven by specific binding of the nucleocapsid (NC) domain of the viral Gag protein to the packaging signal (Ψ) in the host cell cytosol. However, deletion of regions within Ψ reduces-but does not completely abolish-genome packaging. To probe whether another feature of the gRNA may contribute to the selective gRNA packaging process, we replaced NC with heterologous RNA-binding domains (RBDs) with distinct RNA-binding properties. Surprisingly, despite disparate RNA binding specificities, all Gag-RBD chimeras successfully recruited the gRNA to the plasma membrane, suggesting that the initial gRNA recognition in the cytosol is not rate limiting. Notwithstanding, many chimeras exhibiting G/C binding specificity were arrested at the assembly stage. Only the Gag-SRSF5 chimera, which multimerized efficiently on adenosine-rich sequences on the gRNA, assembled efficiently and packaged gRNA at near wild-type levels. Importantly, rationally designed mutations that altered the A/G-rich binding specificity of Gag-SRSF5 decreased genome encapsidation efficiency. Furthermore, many Gag chimeras displayed potent dominant negative activities, highlighting NC functions as a targetable step in virus replication. Together, our findings reveal an unexpected aspect of the HIV-1 gRNA, its biased nucleotide content, as a key driver of selective genome packaging.

Indexed as

AdenosineGenome, ViralHIV-1RNA, ViralViral Genome PackagingVirus Assemblygag Gene Products, Human Immunodeficiency VirusHEK293 CellsHumansAdenosinegag Gene Products, Human Immunodeficiency VirusRNA, Viralgenome traffickingHIV-1hnRNP/SR proteinsselective genome packagingvirion assembly

Identifiers

PMID41926539
PMCPMC13056067

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.